Award reduced in Texas Vioxx case

Share this article:
A judge in a Texas lawsuit over Merck's Vioxx today reduced a $32 million jury award to $7.75 million, citing Texas' recently enacted caps on punitive damages, according to a story appearing on The Wall Street Journal's Web site.

The state jury in April found Merck liable for the death of Leonel Garza, a 71-year-old man who had a fatal heart attack within a month of taking the withdrawn painkiller. Merck was ordered to pay Garza's family $7 million in non-economic compensatory damages and $25 million in punitive damages.

But Judge Alex Gabert ordered the punitive damage reduced as required by state law. The law caps punitive damages at twice the amount of economic damages – lost pay—and up to $750,000 on top of non-economic damages. Because Garza was retired, the jury awarded no economic damages, so Merck was ordered to pay the most the family could receive under state law.
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...